Chinese Academy of Medical Sciences - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Chinese Academy of Medical Sciences - Department of Medical Oncology, Jilin University (JLU) - First Affiliated Hospital, Academy of Military Sciences, Tianjin Medical University, Hebei Medical University, Peking University - Cancer Hospital and Institute, Huazhong University of Science and Technology, Nanjing Medical University - Jiangsu Institute of Cancer Research, Sun Yat-Sen University (SYSU) Cancer Center - Department of Medical Oncology, Fudan University - Shanghai Cancer Center (FUSCC), Jiangsu Hengrui Medicine Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd.

Chinese PLA General Hospital - The Fifth Medical Center, Department of Medical Oncology, Jilin University (JLU) - First Affiliated Hospital, Fudan University - Shanghai Cancer Center (FUSCC), Harbin Medical University - Cancer Hospital, Liaoning Cancer Hospital & Institute - Department of Medical Oncology, Zhengzhou University - Henan Cancer Hospital, Sun Yat-Sen University (SYSU) Cancer Center - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Jiangsu Province People's Hospital, Tumour Hospital of Hebei Province, Tianjin Medical University, Jilin Cancer Hospital, Anhui Medical University - Department of Medical Oncology, Shandong University - Jinan Central Hospital, Third Hospital of Nanchang, Beijing Cancer Hospital, Anhui Medical University - First Affiliated Hospital, Nanjing Medical University - Jiangsu Institute of Cancer Research, Zhejiang Cancer Hospital - Department of Medical Oncology, Peking University - Shenzhen Hospital, Fudan University, Zhongshan Hospital, Department of Oncology, Cangzhou Central Hospital, Northwestern University - Feinberg School of Medicine, Chipscreen Biosciences Ltd and Chipscreen Biosciences Ltd